Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis

Study Identifier
203818-005
CT.gov Identifier
NCT00380783
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Other
Sign up for trial alerts

Study Details

Medical Condition
  • Bladder Disorder - Interstitial Cystitis
    • Study Drug
  • AGN 203818
    • Phase
    Phase 2
    Sex
    Female
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of painful bladder syndrome/interstitial cystitis * Moderate or severe bladder pain
    Exclusion Criteria:
    * Any other uncontrolled disease * Pregnant or nursing females

    Protocol Summary

    This study will explore the safety and effectiveness of different doses of AGN 203818 in treating the pain associated with painful bladder syndrome/interstitial cystitis

    Study Locations

    Location
    Status
    Location
    Oklahoma City, Oklahoma, United States
    Status
    Not applicable